# Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation

> **NCT03300960** · PHASE3 · COMPLETED · sponsor: **Instituto Valenciano de Infertilidad, IVI VALENCIA** · enrollment: 318 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Provera 10 mg.
- **DRUG:** Ganirelix (GnRH antagonist)

## Key facts

- **NCT ID:** NCT03300960
- **Lead sponsor:** Instituto Valenciano de Infertilidad, IVI VALENCIA
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-20
- **Primary completion:** 2019-06-25
- **Final completion:** 2019-06-25
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03300960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03300960, "Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03300960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*